AURA
Price
$6.50
Change
+$0.41 (+6.72%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
378.54M
62 days until earnings call
DSGN
Price
$4.03
Change
+$0.03 (+0.75%)
Updated
Jun 6, 04:15 PM (EDT)
Capitalization
227.07M
66 days until earnings call
Interact to see
Advertisement

AURA vs DSGN

Header iconAURA vs DSGN Comparison
Open Charts AURA vs DSGNBanner chart's image
Aura Biosciences
Price$6.50
Change+$0.41 (+6.72%)
Volume$1.74K
Capitalization378.54M
Design Therapeutics
Price$4.03
Change+$0.03 (+0.75%)
Volume$600
Capitalization227.07M
AURA vs DSGN Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. DSGN commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Buy and DSGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (AURA: $6.11 vs. DSGN: $4.00)
Brand notoriety: AURA and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 76% vs. DSGN: 50%
Market capitalization -- AURA: $378.54M vs. DSGN: $227.07M
AURA [@Biotechnology] is valued at $378.54M. DSGN’s [@Biotechnology] market capitalization is $227.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 7 TA indicator(s) are bullish while DSGN’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 7 bullish, 2 bearish.
  • DSGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AURA is a better buy in the short-term than DSGN.

Price Growth

AURA (@Biotechnology) experienced а +0.25% price change this week, while DSGN (@Biotechnology) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

DSGN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($379M) has a higher market cap than DSGN($227M). AURA YTD gains are higher at: -25.730 vs. DSGN (-35.170). DSGN has higher annual earnings (EBITDA): -67.79M vs. AURA (-91.84M). DSGN has more cash in the bank: 230M vs. AURA (174M). DSGN has less debt than AURA: DSGN (2.14M) vs AURA (19.1M). AURA (0) and DSGN (0) have equivalent revenues.
AURADSGNAURA / DSGN
Capitalization379M227M167%
EBITDA-91.84M-67.79M135%
Gain YTD-25.730-35.17073%
P/E RatioN/AN/A-
Revenue00-
Total Cash174M230M76%
Total Debt19.1M2.14M892%
TECHNICAL ANALYSIS
Technical Analysis
AURADSGN
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 24 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 5 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMUEX13.29N/A
N/A
GMO US Equity III
ACIIX8.55N/A
N/A
American Century Equity Income I
MRBPX23.78N/A
N/A
BlackRock Balanced R
SWSCX18.41N/A
N/A
Schwab Small-Cap Equity
CLTAX15.50N/A
N/A
Catalyst/Lyons Tactical Allocation A

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-2.44%
VRDN - DSGN
49%
Loosely correlated
+0.60%
KRYS - DSGN
45%
Loosely correlated
+0.53%
IDYA - DSGN
45%
Loosely correlated
-0.09%
AURA - DSGN
44%
Loosely correlated
-0.57%
TRDA - DSGN
43%
Loosely correlated
+2.14%
More